Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Real World Experience with Biosimilar Medicines in Oncology
Release Date:
Review Process: Pfizer Internal
Education Oncology All
Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD Patients
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology Japan
Improving COVID-19 Outpatient Management (Emerging market countries listed in Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Quality Improvement Hospital All
Quality Improvement in Pediatric Endocrinology fields
Release Date:
Partner: The Japanese Society for Pediatric Endocrinology
Review Process: Expert Review Panel
Quality Improvement Rare Disease Japan
COVID-19 Patient Awareness (United States and Europe)
Release Date:
Review Process: Pfizer Internal
Education Hospital All
Improving Cytogenetic Testing & Treatment Guidance in Adult AML
Release Date:
Review Process: Pfizer Internal
Quality Improvement Oncology Canada
Acromegaly Research- United States
Release Date:
Review Process: Pfizer Internal
Research Rare Disease USA
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Canada
Release Date:
Review Process: Pfizer Internal
Research Rare Disease Canada
Best Practices in the Clinical Management of Patients with BRAF-mutant Metastatic Melanoma
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Innovative Solutions in Atopic Dermatitis and Alopecia Areata Management 2022 I&I IT INNOVA-DERMA
Release Date:
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology Italy
ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy Challenge
Release Date:
Partner: ASTRO and Myovant Sciences
Review Process: Expert Review Panel
Research Oncology USA
Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)
Release Date:
Review Process: Pfizer Internal
Research Hospital All